GWAS-related meQTLs across different cancer types
We identified 2,214,458 meQTLs that overlap with GWAS linkage disequilibrium (LD) regions (r² ≥ 0.5).
Cancer type
|
QTL type
|
tagSNP
|
Gene position (hg19)
|
Gene
|
p-value
|
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BLCA | cis | rs16973500 | 0.808 | rs112121746 | chr16:71874983 | G/A | cg00732059 | chr16:71740210 | PHLPP2 | -0.5 | -6.52 | -0.32 | 2.25E-10 | Response to anti-TNF therapy in rheumatoid arthritis;Attention deficit hyperactivity disorder and conduct disorder; |
BLCA | cis | rs9937943 | 0.72 | rs112685216 | chr16:74609517 | G/A | cg01733217 | chr16:74700730 | RFWD3 | 0.55 | 6.46 | 0.31 | 3.24E-10 | Neutrophil percentage of white cells; |
BLCA | cis | rs9399135 | 0.684 | rs1135205 | chr6:135281795 | C/T | cg24558204 | chr6:135376177 | HBS1L | 0.6 | 9.52 | 0.44 | 2.11E-19 | Red blood cell count; |
BLCA | cis | rs7582720 | 1 | rs114123510 | chr2:203831212 | T/A | cg15057621 | chr2:203777863 | WDR12;ALS2CR8 | 0.89 | 9.49 | 0.44 | 2.61E-19 | Coronary artery disease or ischemic stroke;Coronary artery disease or large artery stroke; |
BLCA | cis | rs6582630 | 0.502 | rs11522899 | chr12:38270637 | T/C | cg13010199 | chr12:38710504 | ALG10B | 0.67 | 10.93 | 0.49 | 2.37E-24 | Drug-induced liver injury (flucloxacillin); |
BLCA | cis | rs6502050 | 0.723 | rs11650635 | chr17:80083816 | T/C | cg23985595 | chr17:80112537 | CCDC57 | 0.37 | 7.2 | 0.35 | 3.26E-12 | Life satisfaction; |
BLCA | cis | rs12950390 | 0.853 | rs11655112 | chr17:45856563 | T/C | cg03474202 | chr17:45855739 | NA | -0.31 | -6.69 | -0.32 | 8.1E-11 | IgG glycosylation; |
BLCA | cis | rs6466055 | 0.72 | rs1204058 | chr7:104958129 | T/G | cg04380332 | chr7:105027541 | SRPK2 | 0.52 | 8.5 | 0.4 | 4.52E-16 | Schizophrenia; |
BLCA | cis | rs208520 | 0.69 | rs12189780 | chr6:66759619 | G/A | cg07460842 | chr6:66804631 | NA | 0.94 | 16.21 | 0.64 | 2.6E-45 | Exhaled nitric oxide output; |
BLCA | cis | rs208520 | 0.69 | rs12213581 | chr6:66735818 | T/C | cg07460842 | chr6:66804631 | NA | 0.93 | 15.74 | 0.63 | 2.4E-43 | Exhaled nitric oxide output; |
BLCA | cis | rs873946 | 0.564 | rs12263364 | chr10:134555548 | G/T | cg27297192 | chr10:134578999 | INPP5A | 0.35 | 6.74 | 0.33 | 5.75E-11 | Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect); |
BLCA | cis | rs4423214 | 1 | rs12278461 | chr11:71182185 | C/T | cg24826892 | chr11:71159390 | DHCR7 | 0.42 | 6.05 | 0.3 | 3.42E-9 | Vitamin D levels; |
BLCA | cis | rs6582630 | 0.519 | rs12372510 | chr12:38293074 | T/C | cg26384229 | chr12:38710491 | ALG10B | 0.74 | 13.59 | 0.57 | 1.48E-34 | Drug-induced liver injury (flucloxacillin); |
BLCA | cis | rs3096299 | 0.685 | rs12446145 | chr16:89542695 | C/T | cg06640241 | chr16:89574553 | SPG7 | 0.81 | 14.81 | 0.6 | 1.7E-39 | Multiple myeloma (IgH translocation); |
BLCA | cis | rs769267 | 0.965 | rs12460764 | chr19:19431963 | G/T | cg20644253 | chr19:19431407 | KIAA0892;SF4 | -0.54 | -8.24 | -0.39 | 2.81E-15 | Tonsillectomy; |